Koyfin Home > Directory > Health Care > Kezar Life Sciences Inc > Capital Expenditures

Kezar Life Sciences Inc Capital Expenditures Chart (KZR)

Kezar Life Sciences Inc annual/quarterly Capital Expenditures from 2017 to 2020.
  • Kezar Life Sciences Inc Capital Expenditures for the quarter ending June 06, 2020 was $0m a -288.24% increase of 0m year over year
  • Kezar Life Sciences Inc Capital Expenditures for the last 12 months ending June 06, 2020 was $0m a -263.92% increase of 1m year over year
  • Kezar Life Sciences Inc Annual Capital Expenditures for 2019 was $-1m a -84.51% increase of 1m from 2018
  • Kezar Life Sciences Inc Annual Capital Expenditures for 2018 was $-1m a 65.27% decrease of -1m from 2017
  • Kezar Life Sciences Inc Annual Capital Expenditures for 2017 was $0m a 66.07% decrease of 0m from 2016
Other Cash Flow Metrics:
  • Kezar Life Sciences Inc Cash Flow from Operations for the quarter ending September 09, 2018 was $-5m a 52.69% decrease of -2m year over year
  • Kezar Life Sciences Inc Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-4m
View Chart On Koyfin

Quarterly KZR Capital Expenditures Data

06/2020$0m
03/2020$0m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$0m
12/2018$0m
09/2018$0m
06/2018$-1m
03/2018$0m

Annual KZR Capital Expenditures Data

2019$-1m
2018$-1m
2017$0m
2016$0m